Evolus, Inc. (EOLS) Q2 2025 Earnings Call Transcript

2025-08-05 19:15:46 ET

Evolus, Inc. (EOLS)

Q2 2025 Earnings Conference Call

August 05, 2025, 04:30 PM ET

Company Participants

David Moatazedi - President, CEO & Director

Nareg Sagherian - Head of Global Investor Relations & Corporate Communications

Rui Avelar - Chief Medical Officer and Head of Research & Development

Conference Call Participants

Annabel Eva Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division

Douglas Dylan Tsao - H.C. Wainwright & Co, LLC, Research Division

Marc Harold Goodman - Leerink Partners LLC, Research Division

Navann Ty Dietschi - BNP Paribas Exane, Research Division

Sam Shimon Eiber - BTIG, LLC, Research Division

Serge D. Belanger - Needham & Company, LLC, Research Division

Uy Sieng Ear - Mizuho Securities USA LLC, Research Division

Presentation

Operator

Good afternoon, everyone, and thank you for standing by. Welcome to Evolus' Second Quarter Earnings Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded and webcast live. [Operator Instructions] I would now like to turn the conference over to Nareg Sagherian, Vice President and Head of Global Investor Relations and Corporate Communications. Please go ahead....

Read the full article on Seeking Alpha

For further details see: